2017 CPIP-E Case 5: Molecular Pathology – Cell-free DNA Screening for Fetal Aneuploidy - CPIP0505Q.2017
Untitled Document


This clinical pathology activity is intended for pathologists and residents.

Credit Type: CME, SAM, CPD
Duration: 1 hour 15 minutes
Launch Date: May 15, 2017
Expiration Date: May 14, 2020 12:00 AM (ET)
Pricing: Junior Member Fee: $10.00
MOC Category: Medical Knowledge, Patient Care

Registration Information
THIS ACTIVITY REQUIRES CREDIT CARD PAYMENT. If you ordered this product in advance, click Learning Search to locate the activity.

To enroll in the series with one easy payment, or to enroll multiple participants from the same institution, contact the CAP at 800-323-4040, option 1. This option is only available until December 31, 2017, after this date this activity is only accessible by an online credit card payment.

Description
The Clinical Pathology Improvement Program (CPIP) uses clinical pathology cases designed to strengthen the interpretive and administrative skills of pathologists.This Self-Assessment Module (SAM) features a challenging Hematology case. You will be presented with information including an introduction, case presentation, laboratory findings, discussions, and a summary. The case includes a series of thought-provoking questions related to the case. These thought-provoking questions are designed as learning opportunities to check your knowledge and therefore are not scored. After you complete the case, you will be presented with a five-question post-test assessment.

Objectives
After completing this SAM eligible activity and post-test, you should be able to:

  1. State the key differences between screening tests and diagnostic tests in the setting of prenatal fetal aneuploidy testing.
  2. Describe the technology and clinical applications of cell-free DNA screening for fetal aneuploidy (noninvasive prenatal screening: (NIPS)).
  3. Compare NIPS with conventional 1st and 2nd trimester maternal serum screening methods and invasive testing, and describe the benefits and limitations.
  4. Describe the ACOG/SMFM/ACMG/CAP guidelines regarding options for fetal aneuploidy screening including the roles for NIPS and genetic counseling.
  5. List the clinical laboratory quality assurance and quality control for cell-free DNA-based NIPS tests used to detect fetal aneuploidy.

Related Link
Clinical Pathology Improvement Program

CME Information
Accreditation: The College of American Pathologists (CAP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CME Category 1: The College of American Pathologists designates this internet enduring material educational activity for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity meets the American Board of Pathology’s (ABP) Maintenance of Certification (MOC) requirements for Self-Assessment Modules (SAMs).

Continuing Professional Development (CPD), Section 3 Credit
Accreditation in Canada: This event is an Accredited Self Assessment Program (Section 3) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, approved by the Canadian Association of Pathologists - Association Canadienne des Pathologistes. You may claim a maximum of 1.25 hours equivalent to 3.75 credits.

Passing Requirements
You have a total of three opportunities to take and pass the post-test. If you correctly answer 70% or more of the post-test items, you may claim credit. CME/SAM credit can be applied to the American Board of Pathology (ABP) Self-Assessment Module (SAM) requirements. The AMA requires that you pass the post-test in an enduring program to claim credit; therefore, if you do not pass, you cannot claim credit.

Attention Canadian Participants: You have three opportunities to take and pass the post-test. If you do not pass the post-test after three attempts, you may still claim CPD credit (self-assessment program credits) for this activity. Please contact a representative of the CAP Learning Division at 800-323-4040, Option 1 or education@cap.org with the name of this activity and the date completed to request a Letter of Participation.

Payment Information
To pay with a check, print a copy of this page and send it with your check to the address below. You will be notified when your payment has been processed and you have been registered into the activity.

College of American Pathologists
Education Division
325 Waukegan Road
Northfield, IL 60093-2750

Refund Policy
Refunds will be handled on an exception basis. Please submit your request to the CAP in writing via email at education@cap.org or fax at 847-832-8006.

Technical Requirements
Pop-up blockers must be turned off.

CAP Learning has recognized that some Veteran’s Administration, US Government, and military participants may have difficulty accessing the online assessment portion of this activity. If you experience difficulty or have any questions, please contact a representative of the CAP Learning Division at 800-323-4040, Option 1 or education@cap.org.

Availability
This activity and evaluation is available May 15, 2017 and will expire on May 14, 2020 12:00 AM (ET). You MUST claim credit by this date and time.





Non-Member Price:     
 
Member Price:    

2017 CPIP-E Case 5: Molecular Pathology – Cell-free DNA Screening for Fetal Aneuploidy